Torrent Pharma Strengthens Control Over JB Chemicals, Clears USFDA Audit with Zero Observations

Torrent Pharma is in focus after two major positive developments – a further increase in its stake in JB Chemicals and a clean USFDA inspection. On January 23, 2026, Torrent acquired 37.8 lakh shares of JB Chemicals (2.36%) from employees. Post this, Torrent now holds 48.75% stake in JB Chemicals on a fully diluted basis. Earlier, it had already acquired the promoter stake of 46.39% from Tau Investment Holdings and completed the open offer, strengthening its control over the company. In another boost, the USFDA inspection at Torrent’s Dahej facility (Jan 19–23) concluded with zero observations, which is a strong regulatory positive for any pharma company. In the last session, the stock closed at ₹3,926.95, down 2.41%. The 52-week high is ₹4,124.95 and low is ₹2,891.45. The stock is currently about 5% below its high and nearly 36% above its low. It has gained 20% over the past year. With a market capitalisation of around ₹1.33 lakh crore, these updates reinforce Torrent Pharma’s strategic expansion and regulatory strength.